专利检索 ap:("Dyax Corp." OR "Bioverativ Therapeutics Inc.") AND inv:"LADNER, Robert,, Charles" 第 1 页

1.

发明公开
ANTIBODIES AGAINST FCRN AND USE THEREOF 审中-公开

公开(公告)号：EP3670538A1

公开(公告)日：2020-06-24

申请号：EP19210915.5

申请日：2009-04-24

申请人： Dyax Corp. , Bioverativ Therapeutics Inc.

发明人： TENHOOR,, Christopher , MURUGANANDAM,, Arumugam , LADNER, Robert,, Charles , WOOD,, Clive , BITONTI,, Alan, J. , STATTEL,, James , MCDONNELL, Kevin , LIU,, Liming , DUMONT,, Jennifer , SATO,, Aaron

IPC分类号： C07K16/28 , A61P37/00 , A61K39/395

摘要： This disclosure provides, inter alia, proteins that bind to FcRn, e.g., immunoglobulins that inhibit FcRn with high affinity and selectivity. The FcRn-binding proteins can be used to treat a variety of disorders including autoimmune disorders.